Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Immunity ; 55(4): 606-622.e6, 2022 04 12.
Article in English | MEDLINE | ID: mdl-35358427

ABSTRACT

Lymph node (LN) stromal cells play a crucial role in LN development and in supporting adaptive immune responses. However, their origin, differentiation pathways, and transcriptional programs are still elusive. Here, we used lineage-tracing approaches and single-cell transcriptome analyses to determine origin, transcriptional profile, and composition of LN stromal and endothelial progenitors. Our results showed that all major stromal cell subsets and a large proportion of blood endothelial cells originate from embryonic Hoxb6+ progenitors of the lateral plate mesoderm (LPM), whereas lymphatic endothelial cells arise from Pax3+ progenitors of the paraxial mesoderm (PXM). Single-cell RNA sequencing revealed the existence of different Cd34+ and Cxcl13+ stromal cell subsets and showed that embryonic LNs contain proliferating progenitors possibly representing the amplifying populations for terminally differentiated cells. Taken together, our work identifies the earliest embryonic sources of LN stromal and endothelial cells and demonstrates that stromal diversity begins already during LN development.


Subject(s)
Endothelial Cells , Endothelial Cells/metabolism , Lymph Nodes , Sequence Analysis, RNA , Single-Cell Analysis , Stromal Cells , Transcription Factors/metabolism
2.
Blood ; 139(2): 165-176, 2022 01 13.
Article in English | MEDLINE | ID: mdl-34610110

ABSTRACT

Cholesterol is a vital lipid for cellular functions. It is necessary for membrane biogenesis, cell proliferation, and differentiation. In addition to maintaining cell integrity and permeability, increasing evidence indicates a strict link between cholesterol homeostasis, inflammation, and hematological tumors. This makes cholesterol homeostasis an optimal therapeutic target for hematopoietic malignancies. Manipulating cholesterol homeostasis by either interfering with its synthesis or activating the reverse cholesterol transport via the engagement of liver X receptors affects the integrity of tumor cells both in vitro and in vivo. Cholesterol homeostasis has also been manipulated to restore antitumor immune responses in preclinical models. These observations have prompted clinical trials involving acute myeloid leukemia to test the combination of chemotherapy with drugs interfering with cholesterol synthesis (ie, statins). We review the role of cholesterol homeostasis in hematopoietic malignancies as well as in cells of the tumor microenvironment and discuss the potential use of lipid modulators for therapeutic purposes.


Subject(s)
Cholesterol/metabolism , Hematologic Neoplasms/metabolism , Animals , Antineoplastic Agents/therapeutic use , Biological Transport/drug effects , Drug Discovery , Hematologic Neoplasms/drug therapy , Homeostasis/drug effects , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Leukemia, Myeloid, Acute/drug therapy , Leukemia, Myeloid, Acute/metabolism , Lipid Metabolism/drug effects , Liver X Receptors/metabolism , Molecular Targeted Therapy
3.
Immunity ; 38(4): 782-91, 2013 Apr 18.
Article in English | MEDLINE | ID: mdl-23601687

ABSTRACT

Secondary lymphoid organ stromal cells comprise different subsets whose origins remain unknown. Herein, we exploit a genetic lineage-tracing approach to show that splenic fibroblastic reticular cells (FRCs), follicular dendritic cells (FDCs), marginal reticular cells (MRCs), and mural cells, but not endothelial cells, originate from embryonic mesenchymal progenitors of the Nkx2-5(+)Islet1(+) lineage. This lineage include embryonic mesenchymal cells with lymphoid tissue organizer (LTo) activity capable also of supporting ectopic lymphoid-like structures and a subset of resident spleen stromal cells that proliferate and regenerate the splenic stromal microenvironment following resolution of a viral infection. These findings identify progenitor cells that generate stromal diversity in spleen development and repair and suggest the existence of multipotent stromal progenitors in the adult spleen with regenerative capacity.


Subject(s)
Dendritic Cells, Follicular/metabolism , Fibroblasts/metabolism , Homeodomain Proteins/metabolism , LIM-Homeodomain Proteins/metabolism , Lymphocytic Choriomeningitis/immunology , Lymphocytic choriomeningitis virus/physiology , Spleen/pathology , Transcription Factors/metabolism , Animals , Cell Differentiation , Cell Lineage , Cells, Cultured , Dendritic Cells, Follicular/pathology , Fibroblasts/pathology , Homeobox Protein Nkx-2.5 , Lymphocytic Choriomeningitis/physiopathology , Mesenchymal Stem Cells/pathology , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Regeneration , Stromal Cells/metabolism , Stromal Cells/pathology
4.
Trends Immunol ; 39(6): 503-514, 2018 06.
Article in English | MEDLINE | ID: mdl-29567327

ABSTRACT

The mammalian spleen is a peripheral lymphoid organ that plays a central role in host defense. Consequently, the lack of spleen is often associated with immunodeficiency and increased risk of overwhelming infections. Growing evidence suggests that non-hematopoietic stromal cells are central players in spleen development, organization, and immune functions. In addition to its immunological role, the spleen also provides a site for extramedullary hematopoiesis (EMH) in response to injuries. A deeper understanding of the biology of stromal cells is therefore essential to fully comprehend how these cells modulate the immune system during normal and pathological conditions. Here, we review the specificities of the different mouse spleen stromal cell subsets and complement the murine studies with human data when available.


Subject(s)
Adaptive Immunity/immunology , Lymphocytes/immunology , Spleen/immunology , Stromal Cells/immunology , Animals , Hematopoiesis, Extramedullary/immunology , Humans , Mice , Signal Transduction/immunology , Spleen/cytology
5.
Blood ; 127(16): 1987-97, 2016 Apr 21.
Article in English | MEDLINE | ID: mdl-26825709

ABSTRACT

Hypoxia-inducible transcription factors (HIFs) regulate a wide array of adaptive responses to hypoxia and are often activated in solid tumors and hematologic malignancies due to intratumoral hypoxia and emerging new layers of regulation. We found that in chronic lymphocytic leukemia (CLL), HIF-1α is a novel regulator of the interaction of CLL cells with protective leukemia microenvironments and, in turn, is regulated by this interaction in a positive feedback loop that promotes leukemia survival and propagation. Through unbiased microarray analysis, we found that in CLL cells, HIF-1α regulates the expression of important chemokine receptors and cell adhesion molecules that control the interaction of leukemic cells with bone marrow and spleen microenvironments. Inactivation of HIF-1α impairs chemotaxis and cell adhesion to stroma, reduces bone marrow and spleen colonization in xenograft and allograft CLL mouse models, and prolongs survival in mice. Of interest, we found that in CLL cells, HIF-1α is transcriptionally regulated after coculture with stromal cells. Furthermore, HIF-1α messenger RNA levels vary significantly within CLL patients and correlate with the expression of HIF-1α target genes, including CXCR4, thus further emphasizing the relevance of HIF-1α expression to CLL pathogenesis.


Subject(s)
Cell Communication/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/physiology , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Tumor Microenvironment/genetics , Animals , Bone Marrow/metabolism , Bone Marrow/pathology , Cell Adhesion/genetics , Chemotaxis, Leukocyte/genetics , Gene Expression Regulation, Leukemic , HEK293 Cells , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Spleen/metabolism , Spleen/pathology , Stromal Cells/metabolism , Stromal Cells/pathology
6.
Cell Death Dis ; 14(2): 129, 2023 02 15.
Article in English | MEDLINE | ID: mdl-36792589

ABSTRACT

Lipid and cholesterol metabolism play a crucial role in tumor cell behavior and in shaping the tumor microenvironment. In particular, enzymatic and non-enzymatic cholesterol metabolism, and derived metabolites control dendritic cell (DC) functions, ultimately impacting tumor antigen presentation within and outside the tumor mass, dampening tumor immunity and immunotherapeutic attempts. The mechanisms accounting for such events remain largely to be defined. Here we perturbed (oxy)sterol metabolism genetically and pharmacologically and analyzed the tumor lipidome landscape in relation to the tumor-infiltrating immune cells. We report that perturbing the lipidome of tumor microenvironment by the expression of sulfotransferase 2B1b crucial in cholesterol and oxysterol sulfate synthesis, favored intratumoral representation of monocyte-derived antigen-presenting cells, including monocyte-DCs. We also found that treating mice with a newly developed antagonist of the oxysterol receptors Liver X Receptors (LXRs), promoted intratumoral monocyte-DC differentiation, delayed tumor growth and synergized with anti-PD-1 immunotherapy and adoptive T cell therapy. Of note, looking at LXR/cholesterol gene signature in melanoma patients treated with anti-PD-1-based immunotherapy predicted diverse clinical outcomes. Indeed, patients whose tumors were poorly infiltrated by monocytes/macrophages expressing LXR target genes showed improved survival over the course of therapy. Thus, our data support a role for (oxy)sterol metabolism in shaping monocyte-to-DC differentiation, and in tumor antigen presentation critical for responsiveness to immunotherapy. The identification of a new LXR antagonist opens new treatment avenues for cancer patients.


Subject(s)
Melanoma , Monocytes , Mice , Animals , Monocytes/metabolism , Cell Differentiation , Cholesterol/metabolism , Antigen Presentation , Dendritic Cells/metabolism , Tumor Microenvironment
7.
Elife ; 112022 10 25.
Article in English | MEDLINE | ID: mdl-36281643

ABSTRACT

Hepatic metastases are a poor prognostic factor of colorectal carcinoma (CRC) and new strategies to reduce the risk of liver CRC colonization are highly needed. Herein, we used mouse models of hepatic metastatization to demonstrate that the continuous infusion of therapeutic doses of interferon-alpha (IFNα) controls CRC invasion by acting on hepatic endothelial cells (HECs). Mechanistically, IFNα promoted the development of a vascular antimetastatic niche characterized by liver sinusoidal endothelial cells (LSECs) defenestration extracellular matrix and glycocalyx deposition, thus strengthening the liver vascular barrier impairing CRC trans-sinusoidal migration, without requiring a direct action on tumor cells, hepatic stellate cells, hepatocytes, or liver dendritic cells (DCs), Kupffer cells (KCs) and liver capsular macrophages (LCMs). Moreover, IFNα endowed LSECs with efficient cross-priming potential that, along with the early intravascular tumor burden reduction, supported the generation of antitumor CD8+ T cells and ultimately led to the establishment of a protective long-term memory T cell response. These findings provide a rationale for the use of continuous IFNα therapy in perioperative settings to reduce CRC metastatic spreading to the liver.


Colorectal cancer remains one of the most widespread and deadly cancers worldwide. Poor health outcomes are usually linked to diseased cells spreading from the intestine to create new tumors in the liver or other parts of the body. Treatment involves surgically removing the initial tumors in the bowel, but patient survival could be improved if, in parallel, their immune system was 'boosted' to destroy cancer cells before they can form other tumors. Interferon alpha is a small protein which helps to coordinate how the immune system recognizes and deactivates foreign agents and cancerous cells. It has recently been trialed as a colorectal cancer treatment to prevent tumors from spreading to the liver, but only with limited success. This partly because interferon-alpha is usually administered in high and pulsed doses, which cause severe side effects through the body. Instead, Tran, Ferreira, Alvarez-Moya et al. aimed to investigate whether continuously delivering lower amounts of the drug could be a better approach. This strategy was tested on mice in which colorectal cancer cells had been implanted into the wall of the large intestine. Continuous administration minimized the risk of the implanted cancer cells spreading to the liver while also creating fewer side effects. The team was able to identify an optimum delivery strategy by varying how much interferon-alpha the animals received and when. Further experiments also revealed a new mechanism by which interferon-alpha prevented the spread of colorectal cancer. Upon receiving continuous doses of the drug, a group of liver cells started to generate a physical barrier which stopped cancer cells from being able to invade the organ. The treatment also promoted long-term immune responses that targeted diseased cells while being safe for healthy tissues. If confirmed in clinical trials, these results suggest that colorectal patients undergoing tumor removal surgery may benefit from also receiving interferon-alpha through continuous delivery.


Subject(s)
Colorectal Neoplasms , Interferon-alpha , Animals , Mice , Endothelial Cells/pathology , CD8-Positive T-Lymphocytes , Liver , Hepatocytes , Colorectal Neoplasms/pathology
8.
Nat Med ; 8(5): 500-8, 2002 May.
Article in English | MEDLINE | ID: mdl-11984595

ABSTRACT

Microarray analysis of multiple sclerosis (MS) lesions obtained at autopsy revealed increased transcripts of genes encoding inflammatory cytokines, particularly interleukin-6 and -17, interferon-gamma and associated downstream pathways. Comparison of two poles of MS pathology--acute lesions with inflammation versus 'silent' lesions without inflammation--revealed differentially transcribed genes. Some products of these genes were chosen as targets for therapy of experimental autoimmune encephalomyelitis (EAE) in mice. Granulocyte colony-stimulating factor is upregulated in acute, but not in chronic, MS lesions, and the effect on ameliorating EAE is more pronounced in the acute phase, in contrast to knocking out the immunoglobulin Fc receptor common gamma chain where the effect is greatest on chronic disease. These results in EAE corroborate the microarray studies on MS lesions. Large-scale analysis of transcripts in MS lesions elucidates new aspects of pathology and opens possibilities for therapy.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/genetics , Interferon-gamma/genetics , Interleukin-17/genetics , Interleukin-6/genetics , Multiple Sclerosis/genetics , Oligonucleotide Array Sequence Analysis , Acute Disease , Animals , Autopsy , Chronic Disease , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Granulocyte Colony-Stimulating Factor/physiology , Humans , Inflammation/genetics , Inflammation/pathology , Mice , Mice, Inbred C57BL , Multiple Sclerosis/pathology , Receptors, Fc/physiology , Reproducibility of Results , Transcription, Genetic
9.
Commun Biol ; 4(1): 1355, 2021 12 02.
Article in English | MEDLINE | ID: mdl-34857864

ABSTRACT

Our understanding of the composition and functions of splenic stromal cells remains incomplete. Here, based on analysis of over 20,000 single cell transcriptomes of splenic fibroblasts, we characterized the phenotypic and functional heterogeneity of these cells in healthy state and during virus infection. We describe eleven transcriptionally distinct fibroblastic cell clusters, reassuring known subsets and revealing yet unascertained heterogeneity amongst fibroblasts occupying diverse splenic niches. We further identify striking differences in innate immune signatures of distinct stromal compartments in vivo. Compared to other fibroblasts and to endothelial cells, Ly6C+ fibroblasts of the red pulp were selectively endowed with enhanced interferon-stimulated gene expression in homeostasis, upon systemic interferon stimulation and during virus infection in vivo. Collectively, we provide an updated map of fibroblastic cell diversity in the spleen that suggests a specialized innate immune function for splenic red pulp fibroblasts.


Subject(s)
Fibroblasts/metabolism , Herpesviridae Infections/virology , Immunity, Innate , Transcriptome , Animals , Female , Fibroblasts/immunology , Homeostasis , Male , Mice , Muromegalovirus/physiology , Single-Cell Analysis , Spleen/immunology , Spleen/metabolism
10.
Mol Genet Genomic Med ; 8(9): e1389, 2020 09.
Article in English | MEDLINE | ID: mdl-32592340

ABSTRACT

BACKGROUND: Milroy-like disease is the diagnostic definition used for patients with phenotypes that resemble classic Milroy disease (MD) but are negative to genetic testing for FLT4. In this study, we aimed at performing a genetic characterization and biochemical analysis of VEGF-C variations found in a female proband born with congenital edema consistent with Milroy-like disease. METHODS: The proband underwent next-generation sequencing-based genetic testing for a panel of genes associated with known forms of hereditary lymphedema. Segregation analysis was performed on family members by direct sequencing. In vitro studies were performed to evaluate the role of a novel identified variant. RESULTS: Two VEGF-C variations were found in the proband, a novel p.(Ser65Arg) and a pathogenic c.148-3_148-2delCA, of paternal and maternal origin, respectively. Functional characterization of the p.(Ser65Arg) variation in vitro showed alterations in VEGF-C processing. CONCLUSIONS: Our findings reveal an interesting case in which biallelic variants in VEGF-C are found in a patient with Milroy-like lymphedema. These data expand our understanding of the etiology of congenital Milroy-like lymphedema.


Subject(s)
Alleles , Lymphedema/genetics , Vascular Endothelial Growth Factor C/genetics , Adult , Child , Female , Humans , Lymphedema/pathology , Male , Middle Aged , Mutation, Missense , Pedigree , Phenotype , Vascular Endothelial Growth Factor C/metabolism
11.
Fertil Steril ; 111(4): 687-698, 2019 04.
Article in English | MEDLINE | ID: mdl-30929729

ABSTRACT

OBJECTIVE: To study pathogenic features of the somatic testicular microenvironment associated with idiopathic germ cell aplasia. DESIGN: Cross-sectional study. SETTING: Tertiary referral center for reproductive medicine. PATIENT(S): Testicular specimens from men with idiopathic nonobstructive azoospermia (iNOA) prospectively submitted to microdissection testicular sperm extraction. Of 20 specimens used for histology, 10 were also available for proteomic analysis. Primary Sertoli cells with normal karyotype and phenotype were also used. INTERVENTION(S): Patients with iNOA were dichotomized according to a positive versus negative sperm retrieval at microdissection testicular sperm extraction, and on the isolated extracellular matrix (ECM) the proteomic analysis was performed. MAIN OUTCOME MEASURE(S): Proteomic analysis of the ECM from testicular specimens with positive versus negative sperm retrieval. Gene ontology enrichment was used to identify upstream regulators based on the 11 deregulated ECM proteins, which were validated by immunohistochemistry and quantitative polymerase chain reaction. Continuous variables were expressed as medians and interquartile range. RESULT(S): Germ cell aplasia was characterized by an increased signaling of the retinoic acid in Sertoli cells and associated with decreased expression of the basal membrane markers nidogen-2 and heparan sulfate proteoglycan-2. Decreased levels of the interstitial matrisome-associated factor IX and its regulator VKORC1 were, instead, coupled with decreased signaling of vitamin K in Leydig cells. An altered expression of a further eight ECM proteins was also found, including laminin-4 and laminin-5. Peripheral levels of the two vitamins were within the reference range in the two cohorts of iNOA men. CONCLUSION(S): We identified the pathogenetic signature of the somatic human testicular microenvironment, providing two vitamin-related mechanistic insights related to the molecular determinants of the idiopathic germ cell aplasia.


Subject(s)
Azoospermia/metabolism , Azoospermia/pathology , Extracellular Matrix/pathology , Testis/metabolism , Vitamin A/metabolism , Vitamin K/metabolism , Adolescent , Cells, Cultured , Cross-Sectional Studies , Extracellular Matrix/metabolism , Humans , Male , Microdissection , Proteomics , Signal Transduction/physiology , Sperm Retrieval , Testis/pathology , Young Adult
12.
Stem Cell Reports ; 12(6): 1260-1268, 2019 06 11.
Article in English | MEDLINE | ID: mdl-31155505

ABSTRACT

Lymph nodes (LNs) are secondary lymphoid tissues that play a critical role in filtering the lymph and promoting adaptive immune responses. Surgical resection of LNs, radiation therapy, or infections may damage lymphatic vasculature and compromise immune functions. Here, we describe the generation of functional synthetic lympho-organoids (LOs) using LN stromal progenitors and decellularized extracellular matrix-based scaffolds, two basic constituents of secondary lymphoid tissues. We show that upon transplantation at the site of resected LNs, LOs become integrated into the endogenous lymphatic vasculature and efficiently restore lymphatic drainage and perfusion. Upon immunization, LOs support the activation of antigen-specific immune responses, thus acquiring properties of native lymphoid tissues. These findings provide a proof-of-concept strategy for the development of functional lympho-organoids suitable for restoring lymphatic and immune cell functions.


Subject(s)
Cells, Immobilized , Extracellular Matrix , Lymph Nodes , Organoids , Regeneration , Tissue Scaffolds/chemistry , Animals , Cells, Immobilized/metabolism , Cells, Immobilized/transplantation , Extracellular Matrix/chemistry , Extracellular Matrix/transplantation , Lymph Nodes/metabolism , Lymph Nodes/transplantation , Mice , Mice, Transgenic , Organoids/metabolism , Organoids/transplantation
13.
Nat Commun ; 9(1): 1787, 2018 05 03.
Article in English | MEDLINE | ID: mdl-29725010

ABSTRACT

In chronic lymphocytic leukemia (CLL), the non-hematopoietic stromal microenvironment plays a critical role in promoting tumor cell recruitment, activation, survival, and expansion. However, the nature of the stromal cells and molecular pathways involved remain largely unknown. Here, we demonstrate that leukemic B lymphocytes induce the activation of retinoid acid synthesis and signaling in the microenvironment. Inhibition of RA-signaling in stromal cells causes deregulation of genes associated with adhesion, tissue organization and chemokine secretion including the B-cell chemokine CXCL13. Notably, reducing retinoic acid precursors from the diet or inhibiting RA-signaling through retinoid-antagonist therapy prolong survival by preventing dissemination of leukemia cells into lymphoid tissues. Furthermore, mouse and human leukemia cells could be distinguished from normal B-cells by their increased expression of Rarγ2 and RXRα, respectively. These findings establish a role for retinoids in murine CLL pathogenesis, and provide new therapeutic strategies to target the microenvironment and to control disease progression.


Subject(s)
Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Stromal Cells/pathology , Tretinoin/physiology , Animals , Cell Line , Chemokine CXCL13/metabolism , Coculture Techniques , Disease Progression , Female , Gene Expression Regulation, Neoplastic , Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Male , Mice, Inbred C57BL , Signal Transduction , Survival Analysis , Tretinoin/metabolism , Tumor Microenvironment
14.
Mol Cell Biol ; 24(12): 5324-31, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15169896

ABSTRACT

Pbx2 is one of four mammalian genes that encode closely related TALE homeodomain proteins, which serve as DNA binding partners for a subset of Hox transcription factors. The expression and contributions of Pbx2 to mammalian development remain undefined, in contrast to the essential roles recently established for family members Pbx1 and Pbx3. Here we report that Pbx2 is widely expressed during embryonic development, particularly in neural and epithelial tissues during late gestation. Despite wide Pbx2 expression, mice homozygous mutant for Pbx2 are born at the expected Mendelian frequencies and exhibit no detectable abnormalities in development and organogenesis or reduction of long-term survival. The lack of an apparent phenotype in Pbx2(-)/(-) mice likely reflects functional redundancy, since the Pbx2 protein is present at considerably lower levels than comparable isoforms of Pbx1 and/or Pbx3 in embryonic tissues. In postnatal bone marrow and thymus, however, Pbx2 is the predominant high-molecular-weight (MW)-isoform Pbx protein detectable by immunoblotting. Nevertheless, the absence of Pbx2 has no measurable effect on steady-state hematopoiesis or immune function in adult mice, suggesting possible compensation by low-MW-isoform Pbx proteins present in these tissues. We conclude that the roles of Pbx2 in murine embryonic development, organogenesis, hematopoiesis, immune responses, and long-term survival are not essential.


Subject(s)
Homeodomain Proteins/genetics , Homeodomain Proteins/physiology , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/physiology , Animals , Embryonic and Fetal Development/genetics , Embryonic and Fetal Development/physiology , Female , Gene Expression Regulation, Developmental , Gene Targeting , Genes, Homeobox , Hematopoiesis/genetics , Hematopoiesis/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Phenotype , Pre-B-Cell Leukemia Transcription Factor 1 , Pregnancy , Proto-Oncogene Proteins/deficiency , Transcription Factors/genetics , Transcription Factors/physiology
15.
Gene Expr Patterns ; 6(7): 747-57, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16434237

ABSTRACT

Pbx3 is a member of the Pbx family of TALE (three amino acid loop extension) class homeodomain transcription factors. These transcription factors are implicated in developmental and transcriptional gene regulation in numerous cell types through their abilities to form hetero-oligomeric DNA-binding complexes. Pbx3 was found to be expressed at high levels in the developing central nervous system (CNS), including a region of the medulla oblongata which is implicated in the control of respiration. Furthermore, as reported, Pbx3-deficient mice develop to term but die within a few hours of birth from central respiratory failure. In this study, we have characterized Pbx3 expression patterns during organogenesis in numerous tissues and organ systems other than the CNS, as a first step toward understanding the potentially overlapping functions of Pbx3 with other Pbx family members during vertebrate development. We have performed in situ hybridization on whole mount and sectioned mouse embryos from gestational day (E) 9 to E16.5. During early organogenesis, until E12.5, Pbx3 expression is found mostly in the embryonic head, forelimbs, and septum transversum, unlike Pbx1 and Pbx2 expression which is more widespread. Conversely, later in organogenesis, Pbx3 expression becomes more widely detectable throughout the developing embryo. Epithelial and mesenchymal tissues, as well as the CNS, represent major sites of Pbx3 expression. The enteric nervous system also expresses high levels of Pbx3, distinctively in the cells of the ganglia of Auerbach's myenteric nerve plexus, that also express Dlx2 and Notch1. Cartilage is also a site of Pbx3 expression. Interestingly, like Pbx1, Pbx3 is highly expressed in proliferating chondrocytes but is lost as chondrocytes become hypertrophic during endochondral ossification. Finally, Pbx3 is expressed only in the forelimb buds during early limb development, while the hindlimb bud is devoid of Pbx3. This finding leads us to add Pbx3 to the sparse list of early forelimb-specific molecular markers.


Subject(s)
Embryo, Mammalian/metabolism , Homeodomain Proteins/genetics , Organogenesis/genetics , Proto-Oncogene Proteins/genetics , Animals , Central Nervous System/embryology , Central Nervous System/metabolism , Digestive System/embryology , Digestive System/metabolism , Embryonic Development , Female , Gene Expression Regulation, Developmental , Heart/embryology , In Situ Hybridization , Male , Mice , Mice, Inbred C57BL , Musculoskeletal System/embryology , Musculoskeletal System/metabolism , Myocardium/metabolism , Organ Specificity , Peripheral Nervous System/embryology , Peripheral Nervous System/metabolism , Respiratory System/embryology , Respiratory System/metabolism , Urogenital System/embryology , Urogenital System/metabolism
16.
Stem Cells Int ; 2016: 8419104, 2016.
Article in English | MEDLINE | ID: mdl-27190524

ABSTRACT

Secondary lymphoid organs (SLOs) are sites that facilitate cell-cell interactions required for generating adaptive immune responses. Nonhematopoietic mesenchymal stromal cells have been shown to play a critical role in SLO function, organization, and tissue homeostasis. The stromal microenvironment undergoes profound remodeling to support immune responses. However, chronic inflammatory conditions can promote uncontrolled stromal cell activation and aberrant tissue remodeling including fibrosis, thus leading to tissue damage. Despite recent advancements, the origin and role of mesenchymal stromal cells involved in SLO development and remodeling remain unclear.

17.
J Clin Invest ; 126(7): 2452-64, 2016 07 01.
Article in English | MEDLINE | ID: mdl-27214556

ABSTRACT

The molecular mechanisms that underlie spleen development and congenital asplenia, a condition linked to increased risk of overwhelming infections, remain largely unknown. The transcription factor TLX1 controls cell fate specification and organ expansion during spleen development, and Tlx1 deletion causes asplenia in mice. Deregulation of TLX1 expression has recently been proposed in the pathogenesis of congenital asplenia in patients carrying mutations of the gene-encoding transcription factor SF-1. Herein, we have shown that TLX1-dependent regulation of retinoic acid (RA) metabolism is critical for spleen organogenesis. In a murine model, loss of Tlx1 during formation of the splenic anlage increased RA signaling by regulating several genes involved in RA metabolism. Uncontrolled RA activity resulted in premature differentiation of mesenchymal cells and reduced vasculogenesis of the splenic primordium. Pharmacological inhibition of RA signaling in Tlx1-deficient animals partially rescued the spleen defect. Finally, spleen growth was impaired in mice lacking either cytochrome P450 26B1 (Cyp26b1), which results in excess RA, or retinol dehydrogenase 10 (Rdh10), which results in RA deficiency. Together, these findings establish TLX1 as a critical regulator of RA metabolism and provide mechanistic insights into the molecular determinants of human congenital asplenia.


Subject(s)
Homeodomain Proteins/physiology , Signal Transduction , Spleen/growth & development , Tretinoin/metabolism , Animals , Cell Differentiation , Cell Lineage , Female , Gene Deletion , Heterozygote , Homozygote , Mesenchymal Stem Cells/cytology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mutation
18.
Cell Rep ; 3(4): 1321-33, 2013 Apr 25.
Article in English | MEDLINE | ID: mdl-23602564

ABSTRACT

The interactions of Meis, Prep, and Pbx1 TALE homeoproteins with Hox proteins are essential for development and disease. Although Meis and Prep behave similarly in vitro, their in vivo activities remain largely unexplored. We show that Prep and Meis interact with largely independent sets of genomic sites and select different DNA-binding sequences, Prep associating mostly with promoters and housekeeping genes and Meis with promoter-remote regions and developmental genes. Hox target sequences associate strongly with Meis but not with Prep binding sites, while Pbx1 cooperates with both Prep and Meis. Accordingly, Meis1 shows strong genetic interaction with Pbx1 but not with Prep1. Meis1 and Prep1 nonetheless coregulate a subset of genes, predominantly through opposing effects. Notably, the TALE homeoprotein binding profile subdivides Hox clusters into two domains differentially regulated by Meis1 and Prep1. During evolution, Meis and Prep thus specialized their interactions but maintained significant regulatory coordination.


Subject(s)
DNA/metabolism , Homeodomain Proteins/metabolism , Animals , Binding Sites , Embryo, Mammalian/metabolism , Genome , Homeodomain Proteins/genetics , Mice , Myeloid Ecotropic Viral Integration Site 1 Protein , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Pre-B-Cell Leukemia Transcription Factor 1 , Promoter Regions, Genetic , Protein Binding , Thymocytes/metabolism , Transcription Factors/metabolism , Transcription Initiation Site
19.
Front Immunol ; 3: 381, 2012.
Article in English | MEDLINE | ID: mdl-23248630

ABSTRACT

Secondary lymphoid tissues such as lymph nodes are essential for the interactions between antigen presenting cells and lymphocytes that result in adaptive immune responses that protect the host against invading pathogens. The specialized architecture of these organs facilitates the cognate interactions between antigen-loaded dendritic cells and lymphocytes expressing their specific receptor as well as B-T cell interactions that are at the core of long lasting adaptive immune responses. Lymph nodes develop during embryogenesis as a result of a series of cross-talk interactions between a hematopoietically derived cell lineage called lymphoid tissue inducer cells and stromal cells of mesenchymal origin to form the anlagen of these organs. This review will present an overview of the different signaling pathways and maturation steps that mesenchymal cells undergo during the process of lymph node formation such as cell specification, priming, and maturation to become lymphoid tissue stromal organizer cells.

20.
Dev Cell ; 22(5): 913-26, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22560297

ABSTRACT

The molecular determinants of spleen organogenesis and the etiology of isolated congenital asplenia (ICA), a life-threatening human condition, are unknown. We previously reported that Pbx1 deficiency causes organ growth defects including asplenia. Here, we show that mice with splenic mesenchyme-specific Pbx1 inactivation exhibit hyposplenia. Moreover, the loss of Pbx causes downregulation of Nkx2-5 and derepression of p15Ink4b in spleen mesenchymal progenitors, perturbing the cell cycle. Removal of p15Ink4b in Pbx1 spleen-specific mutants partially rescues spleen growth. By whole-exome sequencing of a multiplex kindred with ICA, we identify a heterozygous missense mutation (P236H) in NKX2-5 showing reduced transactivation in vitro. This study establishes that a Pbx/Nkx2-5/p15 regulatory module is essential for spleen development.


Subject(s)
Homeodomain Proteins/genetics , Spleen/abnormalities , Splenic Diseases/genetics , Transcription Factors/genetics , Adolescent , Amino Acid Sequence , Animals , Cells, Cultured , Cyclin-Dependent Kinase Inhibitor p15/metabolism , DNA-Binding Proteins/deficiency , Exome , Female , Gene Expression Profiling , Gene Expression Regulation, Developmental , Homeobox Protein Nkx-2.5 , Homeodomain Proteins/metabolism , Humans , Infant , Male , Mice , Mice, Transgenic , Molecular Sequence Data , Mutation, Missense , Pedigree , Pre-B-Cell Leukemia Transcription Factor 1 , Proto-Oncogene Proteins/deficiency , Transcription Factors/deficiency , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL